Search research articles
Contact Us
Filters
Showing results (51-60 of 227) with videos related to
Page
of 23
Sort By:
Trends in Cardiovascular Medicine
|
January 18, 2011
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors
C Patrono, G Davi, G Ciabattoni
Critical Reviews in Oncology/Hematology
|
October 1, 1995
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment
R Landolfi, B Rocca, C Patrono
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1983
Low-dose aspirin is a selective inhibitor of platelet cyclooxygenase activity in healthy subjects
P Patrignani, P Filabozzi, C Patrono
The Mount Sinai Journal of Medicine, New York
|
March 1, 1992
Human eicosanoid biosynthesis and metabolism
C Patrono, G Ciabattoni, P Patrignani
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1991
Thromboxane-dependent platelet activation as a transducer of enhanced risk of coronary and cerebral thrombosis
C Patrono, G Ciabattoni, G Davì
Agents and Actions. Supplements
|
January 1, 1992
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors
C Patrono, G Davì, G Ciabattoni
Seminars in Thrombosis and Hemostasis
|
October 1, 1991
In vivo platelet activation in diabetes mellitus
A Strano, G Davì, C Patrono
Journal of Lipid Mediators
|
March 1, 1993
Thromboxane biosynthesis and metabolism in cardiovascular and renal disease
C Patrono, P Patrignani, G Daví
Methods in Enzymology
|
January 1, 1990
Radioimmunoassay of 11-dehydrothromboxane B2
G Ciabattoni, P Patrignani, C Patrono
Kidney International
|
June 1, 1992
Thromboxane synthesis and action within the kidney
G Remuzzi, G A FitzGerald, C Patrono
Page
of 23
Search research articles
Search
Showing results (51-60 of 227) with videos related to
Sort By:
Page
of 23
Trends in Cardiovascular Medicine
|
January 18, 2011
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors
C Patrono, G Davi, G Ciabattoni
Critical Reviews in Oncology/Hematology
|
October 1, 1995
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment
R Landolfi, B Rocca, C Patrono
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1983
Low-dose aspirin is a selective inhibitor of platelet cyclooxygenase activity in healthy subjects
P Patrignani, P Filabozzi, C Patrono
The Mount Sinai Journal of Medicine, New York
|
March 1, 1992
Human eicosanoid biosynthesis and metabolism
C Patrono, G Ciabattoni, P Patrignani
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1991
Thromboxane-dependent platelet activation as a transducer of enhanced risk of coronary and cerebral thrombosis
C Patrono, G Ciabattoni, G Davì
Agents and Actions. Supplements
|
January 1, 1992
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors
C Patrono, G Davì, G Ciabattoni
Seminars in Thrombosis and Hemostasis
|
October 1, 1991
In vivo platelet activation in diabetes mellitus
A Strano, G Davì, C Patrono
Journal of Lipid Mediators
|
March 1, 1993
Thromboxane biosynthesis and metabolism in cardiovascular and renal disease
C Patrono, P Patrignani, G Daví
Methods in Enzymology
|
January 1, 1990
Radioimmunoassay of 11-dehydrothromboxane B2
G Ciabattoni, P Patrignani, C Patrono
Kidney International
|
June 1, 1992
Thromboxane synthesis and action within the kidney
G Remuzzi, G A FitzGerald, C Patrono
Page
of 23